MR R & D (Research & Development)
Group Leader,
Lawrence Ryner
The Magnetic Resonance Research and Development (MR R&D) Group, formed in April of 2003, is located in two cities, Winnipeg and Halifax, and has MR systems in three locations: the NRC-Institute for Biodiagnostics in Winnipeg; the Department of Radiology in the Health Sciences Centre, Winnipeg; and the Neuroimaging Research Laboratory in Queen Elizabeth II Hospital, Halifax, NS.
Currently, the group has ten research officers, three research council officers, and three technical officers. Four of the research officers, one research council officer and one technical officer are located in Halifax. Two administrative assistants, one in Halifax and one in Winnipeg, support the group administratively.
Mission Statement
The mission of the MR R&D Group is to advance our basic hardware, technique, and software research in the field of magnetic resonance into the clinical realm to improve detection, characterization, and monitoring of diseases and disorders.
In order to accomplish this mission the following activities are emphasized:
- To promote MR research clusters by collaborating with scientists, medical researchers and clinicians in Winnipeg, Halifax, and around the world.
- To design and develop new MR hardware/software and methodologies that exploit markers or surrogate markers of disease and disorders to improve clinical procedures.
- To design research and development programs around diseases that specifically affect local and Canadian populations.
- To perform clinical trials and animal studies that demonstrate the usefulness of our developed technologies for clinical purposes and clarify the processes by which they advance their clinical usefulness.
- To identify business partners that will take the developed and/or tested technologies to market.
|
